METASTASES TO KIDNEY side effect
What is METASTASES TO KIDNEY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
METASTASES TO KIDNEY and Recently Reported Side Effects
METASTASES TO KIDNEY and 15 most Active Side Effect polls
METASTASES TO KIDNEY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Revlimib Side Effects Report #5368521-5
Health Professional from UNITED STATES reported REVLIMIB problem on June 12, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMIB. After drug was administered, patient experienced the following problems/side effects: metastases to kidney, . REVLIMIB dosage: 15 MG, X 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5654261-1
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 26, 2008. Female patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to kidney, multiple myeloma, . REVLIMID dosage: 15 MG, X 21 DAYS, ORAL. Patient recovered.
Rituximab Side Effects Report #5382055-3
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 28, 2007. Male patient, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: computerised tomogram abnormal, metastases to kidney, metastases to lung, neoplasm malignant, poisoning, . RITUXIMAB dosage: UNK MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient died on 04/20/2007.
Rituximab Side Effects Report #5382055-3
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 28, 2007. Male patient, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: computerised tomogram abnormal, metastases to kidney, metastases to lung, neoplasm malignant, poisoning, . RITUXIMAB dosage: UNK MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient died on 04/20/2007.
Revlimid Side Effects Report #5710485-6
Physician from UNITED STATES reported REVLIMID problem on Apr 07, 2008. Female patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, metastases to kidney, . REVLIMID dosage: 15 MG, X 21 DAYS, ORAL. Patient recovered.
Avonex Side Effects Report #5689809-4
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2008. Male patient, 67 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, lung neoplasm malignant, metastases to kidney, metastases to liver, pain, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5619225-2
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Jan 23, 2008. Male patient, 67 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: flank pain, metastases to kidney, metastases to liver, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Elidel Side Effects Report #5712316-7
ELIDEL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2008. Male patient, child 6 years of age, weighting 46.00 lb, was diagnosed with eczema and was treated with ELIDEL. After drug was administered, patient experienced the following problems/side effects: anaplastic large cell lymphoma t- and null-cell types stage iii, metastases to bone, metastases to kidney, metastases to lung, metastases to spine, . ELIDEL dosage: unknown. Patient was hospitalized. Patient recovered.
Renagel Side Effects Report #5299209-7
Physician from UNITED STATES reported RENAGEL problem on Apr 02, 2007. Female patient, 81 years of age, weighting 100.0 lb, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: metastases to bone, metastases to gastrointestinal tract, metastases to kidney, pneumonia, pulmonary oedema, refusal of treatment by patient, . RENAGEL dosage: unknown. During the same period patient was treated with COZAAR, ASACOL, LABETALOL HYDROCHLORIDE, NORVASC, ISOSORBIDE MONONITRATE, HOME OXYGEN, ZEMPLAR, EPOGEN. Patient was hospitalized. Patient recovered.
Renagel Side Effects Report #5282591-4
RENAGEL problem was reported by a Physician from UNITED STATES on Mar 13, 2007. Female patient, 81 years of age, weighting 100.0 lb, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: appendix disorder, metastases to bone, metastases to kidney, metastases to lung, metastasis, pneumonia, pulmonary oedema, refusal of treatment by patient, . RENAGEL dosage: unknown. During the same period patient was treated with COZAAR, ASACOL, LABETALOL HYDROCHLORIDE, NORVASC, ISOSORBIDE MONONITRATE, HOME OXYGEN, ZEMPLAR, EPOGEN. Patient was hospitalized. Patient recovered.